Skip to content
    British Business Bank logo

    British Business Bank

    Sheffield, United KingdomFounded 2014

    British Business Bank is the UK government's economic development bank, wholly owned by HM Government, that supports smaller businesses' access to debt and equity finance by working through accredited lenders and fund managers. Headquartered in Sheffield, it operates programmes such as British Patient Capital, the Start Up Loans scheme, and the Enterprise Finance Guarantee.

    Deal activity increased 85% year-over-year (24 deals in the last 12 months). Average disclosed round size is $88.6M (across 70 rounds with reported amounts).

    Find people at British Business Bank on Goldilocks AI

    Portfolio

    89

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    24

    Team

    IC

    Ian Connatty

    Managing Partner, BBB Investment Services and Deputy Chief Investment Officer of British Business Bank

    AK

    Adam Kelly

    Managing Director & Co-Head of Funds

    BM

    Barry Murphy

    Managing Director, Risk and Compliance

    BS

    Bernie Skivington

    Managing Director, Relationship Management

    CL

    Charlotte Lawrence

    Managing Director, Direct Equity

    CH

    Christine Hockley

    Managing Director & Co-Head of Funds

    GF

    Graeme Fisher

    Managing Director, Strategy, Sustainability and Public Affairs

    GM

    Guy Morrell

    Managing Director, IT Operations

    LM

    Louise McCoy

    Managing Director, Start Up Loans Products

    MS

    Mark Sims

    Managing Director, Development Equity Funds

    MW

    Mary Whenman

    Managing Director, Communications and Marketing

    MA

    Matt Adey

    Managing Director, Economics and Performance Measurement

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    126 investments
    CompanyRoundAmountDate
    OMass Therapeutics logoOMass TherapeuticsSeries C$310MOct 2026
    Salience Labs logoSalience LabsSeries B$125MOct 2026
    Draig Therapeutics logoDraig TherapeuticsSeries B$65MJul 2026
    Alchemab logoAlchemabSeries A$25MJul 2026
    Alchemab Therapeutics logoAlchemab TherapeuticsSeries A$25MJul 2026
    Oxford Quantum Circuits logoOxford Quantum CircuitsSeries C—Jun 2026
    IMU Biosciences logoIMU BiosciencesSeries A$53MJun 2026
    Elliptic logoEllipticSeries D$120MMay 2026
    Quantum Motion logoQuantum MotionSeries C$160MMay 2026
    Cytospire Therapeutics logoCytospire TherapeuticsSeries A—May 2026
    Storm Therapeutics logoStorm TherapeuticsSeries C$56MApr 2026
    Dexory logoDexorySeries C—Mar 2026
    Regeno logoRegenoSeed$533KMar 2026
    PPayrSeed$2.1MMar 2026
    Satellite Vu logoSatellite VuUnknown$40MFeb 2026
    Nami Surgical logoNami SurgicalSeed—Feb 2026
    DDataline LabsPre-Seed$1MFeb 2026
    Tenpoint Therapeutics logoTenpoint TherapeuticsSeries B—Jan 2026
    Stream logoStreamSeries D$90MJan 2026
    NNuclera LtdSeries C$87MJan 2026
    BBloemteknikUnknown$3.2MJan 2026
    Kraken logoKrakenGrowth—Jan 2026
    SatVu logoSatVuUnknown—Jan 2026
    Cytospire Therapeutics logoCytospire TherapeuticsSeries A$61MJan 2026
    Oxford Quantum Circuits logoOxford Quantum CircuitsSeries C—Jan 2026
    Page 1 of 6

    Top Co-Investors

    Last updated: 20 October 2026